Article
Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.
International journal of chronic obstructive pulmonary disease - 1 Jan 2015
Zhang Jian-Qing, Zhang Jia-Qiang, Liu Hua, Zhao Zhi-Huan, Fang Li-Zhou, Liu Ling, Fu Wei-Ping, Shu Jing-Kui, Feng Jia-Gang, Dai Lu-Ming
Abstract excerpt
BACKGROUND: The role of the antioxidant N-acetylcysteine (NAC) in the treatment of chronic obstructive pulmonary disease (COPD) has not been clarified as yet. In early studies, we found that the proportion of smokers with COPD having extremely slow/slow microsomal epoxide hydrolase (EPHX1) enzyme activity is significantly higher than that in healthy smokers. The purpose of this study was to evaluate whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
